Fig. 1.
Interaction diagram showing docking pose of lopinavir (A), hydroxychloroquine, ribavirin (C), umifenovir (D), ascorbate (E) and remdesivir (F) at the interface of the receptor-binding domain of SARS-CoV2 spike glycoprotein and human ACE2. Docking grid used generated using binding residues at the interface of interaction.